ciprofloxacin has been researched along with Diabetic Retinopathy in 2 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sierpina, DI | 1 |
| Ng, CCT | 1 |
| Rauser, ME | 1 |
| Fan, JT | 1 |
| Wahab, S | 1 |
| Ahmed, J | 1 |
2 other studies available for ciprofloxacin and Diabetic Retinopathy
| Article | Year |
|---|---|
Ciprofloxacin and Conjunctival Flora Resistance after Intravitreal Injection.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Bacterial Agents; Ciprofloxacin; Conju | 2019 |
Management of cataract with macular oedema due to diabetes mellitus type-II and hypertension with grid laser prior to surgery and intra-vitreal bevacizumab (Avastin) peroperatively.
Topics: Adult; Angiogenesis Inhibitors; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclo | 2010 |